AAAAI logo

Home

Allergy & Asthma Disease Management Center
Funded by an educational grant from sanofi-aventis US


Ask the Expert Current Literature Quiz of the Month Allergy/Respiratory Digest CME Article Meetings/Calendars AAAAI Educational Resources Other Links Comments/Suggestions



June 2006 QUIZ OF THE MONTH . . .

Concerns have been raised about the possible suppression of the growth in height of asthmatic children treated chronically with inhaled corticosteroids (ICS). Which of the statements below about ICS treatment in children are true or false?

  1. Almost all of the ICS dose reaching the lungs is then absorbed systemically.
  2. The delivery system used does not affect how much of a dose of the ICS is absorbed systemically.
  3. There is commonly suppression of growth velocity during the first year moderate dose ICS therapy in asthmatics.
  4. Untreated persistent asthma does not reduce growth velocity.
  5. The mean height is lower than predicted in asthmatic children after treatment for several years with moderate dose ICS.


    Think you have the answers?

Click here to find out if you're right!

<== Back



Please tell us what you think of this site.